Founding Editorial Board Meeting of the JGO. Date & Time: November 14 th (Sat) 2015, 6:30~7:30AM Venue: Crystal Ballroom (2F) Lotte Hotel, Seoul

Similar documents
2 nd JGO Editorial Board Meeting. Date & Time: 12 November 2016, 12:00~13:00PM Venue: 1F, Conference Building, Sendai Int l Center, Sendai

History of ASGO and International Collaboration. Kurume University, Kurume, Japan Toshiharu Kamura, MD, PhD.

Preoperative risk assessment for lymph node metastasis in endometrial cancer (PALME study) : results of a Korean Gynecologic Oncology Group study

Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer : a validation study of the GOG criteria

Incidence and Predictors of Stent Thrombosis after Percutaneous Coronary Intervention in Acute Myocardial Infarction

Tae-Wook Kong 1,2, Joo-Hyuk Son 1,2, Jiheum Paek 1,2, Yonghee Lee 1,3, Eun Ju Lee 1,4, Suk-Joon Chang 1,2, Hee-Sug Ryu 1,2

ASGO The 4th International Workshop on Gynecologic Oncology

Management of high risk early cervical cancer - a view of surgeon Dan DY Kim, M.D., Ph.D.

An Alternative Triage Strategy Based on Preoperative MRI for Avoiding Trimodality Therapy in Stage IB Cervical Cancer

International. Newsletter of the Japanese Gynecologic Oncology Group (JGOG) Table of Contents

Improvements to the FIGO staging for ovarian cancer: reconsideration of lymphatic spread and intraoperative tumor rupture

TGH Annual Report (2016) Editorial Office

Significance of Ovarian Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma

Epidemiologic characteristics of cervical cancer in Korean women

: Ajou University College of Medicine, Suwon, Korea; Ajou University College of Medicine, Graduate

Invitation. Dear Colleagues, Joong Saeng Cho, M.D.

Impact of body mass index on the prognosis of Korean women with endometrioid adenocarcinoma of the uterus: A cohort study

Clinical statistics of gynecologic cancers in Japan

AOSpine Principles Symposium Daegu

Chapter 2: Initial treatment for endometrial cancer (including histologic variant type)

KAHBPS-O-PL-01 KAHBPS-O-PL-02

HBSN Annual Report (2016) Editorial Office

The type of metastasis is a prognostic factor in disseminated cervical cancer

Role of Surgery in Cervical Cancer & Research Questions

Nomogram predicting risk of lymphocele in gynecologic cancer patients undergoing pelvic lymph node dissection

Korea s Contribution to Radiological Research Included in Science Citation Index Expanded,

Preceptorship at the Yonsei Cancer Center Gastric Cancer Team. Date : July, 2018 Place: Yonsei Cancer Center, Seoul, Korea

PROGRAM. Room A (English Session) (Convention 4F) 17 th (Sat) Nov. 08:00-08:25 Registration 08:25-08:30 Opening Remark

Addictive Benefit of Transarterial Chemoembolization and Sorafenib in Treating Advanced Stage Hepatocelluar Carcinoma: Propensity Analysis

3 rd ASGO Workshop Overview Index... 77

Correspondence should be addressed to Dae Sik Yang;

Neoadjuvant and postoperative chemotherapy with paclitaxel plus cisplatin for the treatment of FIGO stage IB cervical cancer in pregnancy

Author's response to reviews

Impact of Surgery Extent on Survival and Recurrence Rate of Stage ⅠEndometrial Adenocarcinoma

Volume 2. Lecture Notes in Electrical Engineering 215. Kim Chung Eds. IT Convergence and Security IT Convergence and Security 2012.

Second primary colorectal cancer among endometrial cancer survivor: shared etiology and treatment sequelae

Curriculum Vitae. Dissertation Title M.S. Thesis: Regulation of Notch1 signaling by Runx2 during osteoblast differentiation.

Hyun Kee Kim, M.S. Curriculum Vitae

Can the Ovaries be preserved in Selected Cases of Endometrial Cancer?

Comparison of modified Cherney incision and vertical midline incision for management of early stage cervical cancer

SERUM CYSTATIN C CONCENTRATION IS A POWERFUL PROGNOSTIC INDICATOR IN PATIENTS WITH CIRRHOTIC ASCITES

Study of Self-management and Stress-coping of Participants in Marine Sports

Prognostic significance of positive lymph node number in early cervical cancer

Comparison of Quality of Life and Sexuality between Cervical Cancer Survivors and Healthy Women

ALL PRINCIPAL INVESTIGATORS/NURSES/DATA MANAGERS RE: PROTOCOL GOG-0233 ACRIN 6671, REVISION # 9 & #10

Endometrial Cancer. Saudi Gynecology Oncology Group (SGOG) Gynecological Cancer Treatment Guidelines

Disease-Specific Mortality of Differentiated Thyroid Cancer Patients in Korea: A Multicenter Cohort Study

CURRICULUM VITAE CHUL LEE, M.D., Ph.D

2017 Obesity Fact Sheet

Factors predictive of myoinvasion in cases of Complex Atypical Hyperplasia diagnosed on endometrial biopsy or curettage

Seung-Woon Rha, MD, PhD FACC, FAHA, FESC, FSCAI, FAPSIC. Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.

CURRICULUM VITAE , St.Mary s Hospital, The Catholic University of Korea, Seoul, Korea National Boards of Medical Doctor #28022

Nam Cheol Park Sae Woong Kim Du Geon Moon Editors. Penile Augmentation

Staging. Carcinoma confined to the corpus. Carcinoma confined to the endometrium. Less than ½ myometrial invasion. Greater than ½ myometrial invasion

Travel Guide For The Deaf: Korea By E Jin Kim READ ONLINE

CURRICULUM VITAE. KIM JONG MAN, M.D., Ph.D.

The clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population

Prognostic factors and treatment outcome after radiotherapy in cervical cancer patients with isolated para-aortic lymph node metastases

Result of screening and surveillance colonoscopy in young Korean adults < 50 years

면역유전자치료법개발 : 면역결핍환자들에서발병하는바이러스질환과종양의치료를위해 CTLs를이용한세포성면역치료법과수지상세포를이용한종양백신의개발하고, 면역치료의연구자임상을수행하고있음.

Promotion of the Journal of Exercise Rehabilitation to the international level based on journal metrics

Changes in the seroprevalence of IgG anti-hepatitis A virus between 2001 and 2013: experience at a single center in Korea

KHUPO 9 TH ANNUAL INTERNATIONAL PROTEOMICS CONFERENCE

Curriculum Vitae. Education. Experience in Clinic, Teaching, and Research

Staging and Treatment Update for Gynecologic Malignancies

Weekly Versus Triweekly Cisplatin-Based Chemotherapy Concurrent With Radiotherapy in the Treatment of Cervical Cancer

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

Early Surgery in Asymptomatic Severe Aortic Stenosis Pros and Cons

receive adjuvant chemotherapy

Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer

Mica Nanoparticle, STB-HO Eliminates the Human Breast Carcinoma Cells. by Regulating the Interaction of Tumor with its Immune Microenvironment

Correlation of intermediate risk factors with prognostic factors in patients with early cervical cancer

Woo Dae Kang, Ho Sun Choi, Seok Mo Kim

The 1 st Congress of Asian Society of Cardiovascular Imaging

Curriculum Vitae (Last updated: ) Jin-Gu Lee, PhD

Nationwide Cancer Incidence in Korea,

ONCOLOGY LETTERS 3: , 2012

Are there the specific prognostic factors for triplenegative subtype of early breast cancers (pt1-2n0m0)?

Index. B Bilateral salpingo-oophorectomy (BSO), 69

CURRICULUM VITAE PERSONAL INFORMATION EDUCATION AND TRAINING. Degree Field of Study Institution Years

Original Article. Introduction. Tae-Kyu Jang, So-Jin Shin, Hyewon Chung, Sang-Hoon Kwon, Soon-Do Cha, Eunbi Lee, Changmin Shin, Chi-Heum Cho

Gynecologic Cancer InterGroup Cervix Cancer Research Network. The SHAPE Trial

Korean Multicenter Cohort Study of Acute-on- Chronic Liver Failure : Korean Acute-on-Chronic Liver Failure Study (KACLiF)

2 nd INTERNATIONAL SEVERANCE ROBOTIC SURGERY SYMPOSIUM

Liver Cancer Screening in Korea: A Report on the 2008 National Cancer Screening Programme

Adjuvant Chemotherapy in High Risk Patients after Wertheim Hysterectomy 10-year Survivals

Clinics in Orthopedic Surgery's Evolution into an International Journal Based on Journal Metrics

Evolving Treatment Strategies for Cervical Cancer

OIE Reference Laboratory Reports Activities

DIAGNOSTIC SIGNIFICANCE OF CHANGES IN SERUM HUMAN EPIDIDYMIS EPITHELIAL SECRETORY PROTEIN 4 AND CARBOHYDRATE ANTIGEN 125 IN ENDOMETRIAL CARCINOMA

Optimal Duration of Clopidogrel Therapy with DES to Reduce Late Coronary Arterial Thrombotic Event. The DES LATE Trial

Risk assessment of lymph node metastasis before surgery in endometrial cancer: Do we need a clinical trial for low-risk patients?

Indicator Mild Moderate Severe

Radical Radiotherapy for Locally Advanced Cancer of U terine Cervix

Outcomes after radical hysterectomy in patients with early-stage adenocarcinoma of uterine cervix

Short Range Outlook for Steel Demand Autumn OECD Steel Committee, Paris, 10 December Short Range Outlook overview

Ovarian Transposition for Stage Ib Squamous Cell Cervical Cancer - Lack of Effects on Survival Rates?

Abstract. Int J Gynecol Cancer 2006, 16,

Adjuvant Therapies in Endometrial Cancer. Emma Hudson

Predictors and Patterns of recurrence after radical surgery in ampulla of vater cancer: Comparison analysis between early and late recu rrence.

Transcription:

Founding Editorial Board Meeting of the JGO Date & Time: November 14 th (Sat) 2015, 6:30~7:30AM Venue: Crystal Ballroom (2F) Lotte Hotel, Seoul

Objective of this meeting Share the current status of the JGO Share the bright future of the JGO with you!

15 min 25 min 5 min Overview of the Journal 1. General information 2. Editorial information 3. Online usage 4. JGO impact factor and citation analysis 5. New feature & Plan for 2016 Discussion 1. How to decrease time span from submission to first decision? 2. Advertisement plan 3. Any problem expected with online-only journal 4. Reinforcement plan of editorial board - other discipline such as med oncology... 5. JGO educational session during 2016 ASGO workshop e.g) How to be a good writer and reviewer 6. AOB Next EB meeting 1. During the 4 th ASGO workshop on Nov 12~13, 2016 at Sendai

General information Online usage JGO impact factor and citation analysis New feature & Plan for 2016 Any suggestions?

JGO accepted by MEDLINE for indexing Submit your manuscript at mc.manuscriptcentral.com/jgo

Medline vs PubMed in general SCI core vs SCIE Refined MeSH indexing epub

Editorial information Online usage JGO impact factor and citation analysis New feature & Plan for 2016 Any suggestions?

Manuscript submissions by year & manuscript type 300 Manuscript submissions: 2011-2015 year to date 250 200 150 100 50 others correspondence editorial case report review original 0 2011 2012 2013 2014 2015 YTD Manuscript submissions (exclude revised manuscripts) (as of Oct 22, 2015) year 2011 2012 2013 2014 2015 YTD Number 166 225 261 204 188

Number of manuscript by country, 2014 Country of submitting author ( 5 papers/yr) No % Korea 44 17.1 China 32 12.5 Japan 24 9.3 USA 22 8.6 Turkey 20 7.8 India 15 5.8 Italy 12 4.7 Poland 7 2.7 Thailand 7 2.7 Iran 7 2.7 Spain 6 2.3 Egypt 6 2.3

Sixteen countries participate : original & review articles 25 20 15 Eight-one articles published during 2014~2015 10 5 0

Acceptance rates Average ~25% 35% 30% 25% 32% 29% 20% 23% 22% Acceptance rate 15% 17% 10% 5% 0% 2011 2012 2013 2014 2015 YTD

Average days from submission to first decision Decision 2011 2012 2013 2014 2015 YTD Accept 8.8 14.3 10.0 15.8 12.9 Major revision 29.3 24.2 22.0 40.7 36.8 Minor revision 27.3 28.9 30.4 35.4 25.7 Reject 24.3 24.7 23.4 30.6 30.3 Reject-inappropriate 5.9 3.1 2.1 9.4 12.5 Total 19.1 19.0 17.6 26.4 23.6 30 from submission to first decision (days) 25 20 26.4 23.6 15 19.1 19 17.6 10 5 0 2011 2012 2013 2014 2015 YTD

Editorial information Online usage JGO impact factor and citation analysis New feature & Plan for 2016 Any suggestions?

Online Usage: PubMed Central HTML Full Text + Article PDF + Other pages view 160,000 Journal of Gynecologic Oncology Online Usage: PubMed Central, 2010-2014 140,000 120,000 100,000 80,000 60,000 40,000 20,000 0 2010 2011 2012 2013 2014

Geographical Distribution of Online Usage, 2014 Others 31% South Korea 28% Germany 3% Japan 5% France 1% India 6% Turkey 4% China 5% United States 16% Ukraine 1%

Editorial information Online usage JGO impact factor and citation analysis New feature & Plan for 2016 Any suggestions?

2014 JGO impact factor: 2.494 3.0 Impact Factor Trend: 2011~2014 2.5 2.494 2.0 1.5 1.489 1.730 1.600 1.0 0.5 0.0 2010 2011 2012 2013 2014

Citation Analysis 2014 Journal Impact Factor -Cites in 2014 to items published in: 2013 =110 2012 =112 -Number of items published in: 2013 =48 2012 =41 222/89=2.494

Impact factor and competitors? IF trend 2010 2011 2012 2013 2014 J Gynecol Oncol 1.489 1.730 1.600 2.494 Gynecol Oncol 3.760 3.888 3.929 3.687 3.774 Int J Gynecol Cancer 1.558 1.646 1.941 1.949 1.958 5.0 Impact Factors of Journal of Gynecologic Oncology and related journals, 2010-2014 4.0 Impact Factor 3.0 2.0 1.0 0.0 2010 2011 2012 2013 2014 Year J Gynecol Oncol Gynecol Oncol Int J Gynecol Cancer

Category Journal Rank/Quartile in 2013 (n=78, n=202) in 2014 (n=79, n=211) Obstetrics & Gynecology 47/78, Q3, 60% 18/79, Q2, 22% Oncology 159/202, Q4, 78% 122/211, Q3, 58% Journal ranking based on Impact Factor

Retrieved Nov 1 st 2015 from www.scimagojr.com

H index 100 means 100 papers get over 100 citations. Retrieved Nov 1 st 2015 from www.scimagojr.com

Most highly cited articles in 2014 Title Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010 New insights into cervical cancer screening Preoperative [F-18]FDG PET/CT predicts recurrence in patients with epithelial ovarian cancer Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancer Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan Major clinical research advances in gynecologic cancer in 2012 Early human papillomavirus testing predicts residual/recurrent disease after LEEP Analysis of para-aortic lymphadenectomy up to the level of the renal vessels in apparent early-stage ovarian cancer How low is low enough? Evaluation of various risk-assessment models for lymph node metastasis in endometrial cancer: a Korean multicenter study Current status of the National Cancer Screening Program for cervical cancer in Korea, 2009 Cervical cancer prevention program in Jakarta, Indonesia: See and Treat model in developing country Learning curve analysis of robot-assisted radical hysterectomy for cervical cancer: initial experience at a single institution A comparison of uterine papillary serous, clear cell carcinomas, and grade 3 endometrioid corpus cancers using 2009 FIGO staging system Reproductive factors for ovarian cancer in southern Chinese women The relationship between cisplatin resistance and histone deacetylase isoform overexpression in epithelial ovarian cancer cell lines Authors Raungkaewmanee, Supachai; Tangjitgamol, Siriwan; Manusirivithaya, Sumonmal; et al. Lim, Myong Cheol; Moon, Eun-Kyeong; Shin, Aesun; et al. Boone, Jonathan D.; Erickson, Britt K.; Huh, Warner K. Chung, Hyun Hoon; Kwon, Hyun Woo; Kang, Keon Wook; et al. Park, Jeong-Yeol; Kim, Dae-Yeon; Kim, Jong- Hyeok; et al. Chiang, Ying-Cheng; Chen, Chi-An; Chiang, Chun-Ju; et al. Suh, Dong Hoon; Kim, Jae-Weon; Kim, Kidong; et al. Ryu, Aeli; Nam, Kyehyun; Kwak, Jeongja; et al. Chang, Suk-Joon; Bristow, Robert E.; Ryu, Hee-Sug Kang, Sokbom; Lee, Jong-Min; Lee, Jae- Kwan; et al. Lee, Young Hwa; Choi, Kui Son; Lee, Hoo- Yeon; et al. Nuranna, Laila; Aziz, Mohamad Farid; Cornain, Santoso; et al. Yim, Ga Won; Kim, Sang Wun; Nam, Eun Ji; et al. Kim, Ha-Jeong; Kim, Tae-Joong; Lee, Yoo- Young; et al. Pasalich, Maria; Su, Dada; Binns, Colin W.; et al. Kim, Min-Gyun; Pak, Jhang Ho; Choi, Won Ho; et al. Publication Year Vol/Issue Citations in 2014 2012 23/4 22 2013 24/4 9 2012 23/4 7 2012 23/1 7 2012 23/4 7 2013 24/4 6 2013 24/1 6 2012 23/4 6 2013 24/1 6 2012 23/4 5 2012 23/1 5 2012 23/3 5 2013 24/4 5 2013 24/2 5 2013 24/2 5 2012 23/3 5

Editorial information Online usage JGO impact factor and citation analysis New feature & Plan for 2016 Any suggestions?

In 2015 Editorial Board (EB) Renewal of board members 1 st EB meeting during 4 th ASGO Biennial meeting Video article

till Sep. 2015

Plans for next year Switch to online-only journal from Jan 2016 Accepted papers will be published online (PubMed) within 2~4 weeks 4 6 issues a year Readership survey

Items for discussion 1. How to decrease time span from submission to first decision? 2. Advertisement plan 3. Any problem expected with online-only journal? 4. Reinforcement plan of editorial board - other discipline such as med oncol... 5. JGO educational session during 2016 4 th ASGO workshop e.g) How to be a good writer and reviewer 6. AOB

- November 2016 - In Sendai, JAPAN The 4 th International Workshop on Gynecologic Oncology [Date] Nov. 12 (Sat) 13 (Sun), 2016 [Venue] Sendai International Center [President] Nobuo Yaegashi, M.D., PhD. Director of Tohoku University Hospital